ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,039.31
-0.47%
US Tech 100
20,882.00
0.05%
Dow Jones
44,713.52
-0.31%
Brent Oil
75.585
-0.44%
Bitcoin
105,260.66
1.47%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Neuren Pharmaceuticals Limited (NEU) Quote

Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited (NEU)

NewMarket Corporation
14.485
0.015
(0.10%)
Closed January 30 12:00AM
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
14.485
Bid
14.45
Ask
14.49
Volume
355,317
14.31 Day's Range 14.67
10.90 52 Week Range 170.09
Market Cap
1.85B
Previous Close
14.47
Open
14.43
Last Trade
656
@
14.45
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
626,000
Shares Outstanding
127,695,676
Dividend Yield
-
PE Ratio
11.77
Earnings Per Share (EPS)
1.23
Revenue
231.94M
Net Profit
157.08M

About Neuren Pharmaceuticals Limited

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.neurenpharma.com
Headquarters
Auckland, Nzl
Founded
-
Neuren Pharmaceuticals Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker NEU. The last closing price for Neuren Pharmaceuticals was AUD14.47. Over the last year, Neuren Pharmaceuticals shares have traded in a share price range of AUD 10.90 to AUD 170.09.

Neuren Pharmaceuticals currently has 127,695,676 shares outstanding. The market capitalization of Neuren Pharmaceuticals is AUD1.85 billion. Neuren Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.77.

Ask ADVFN Intelligence (AI)

NEU Latest News

More News

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment...

With No Approved Treatments in Rett Syndrome, FDA Decision Highlights Significant Unmet Need ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Neuren Pharmaceuticals Limited (ASX: NEU) announced...

March 03 2020
Business Wire

FDA Grants Orphan Drug Designation for Neuren's NNZ-2591 to Treat Angelman, Phelan-McDermid and Pitt Hopkins Syndromes

Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Neuren’s NNZ-2591 for the treatment of Angelman syndrome...

October 17 2019
Business Wire

Positive Phase 2 Study Results of Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the A...

-- Statistically Significant Improvement Indicates Trofinetide’s Potential for Treating Rett Syndrome-- Trofinetide for Rett Syndrome has Fast Track Status and Orphan Drug Designation in...

March 27 2019
Business Wire

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development & Com...

-ACADIA plans to initiate a Phase 3 study of trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental congenital CNS disorder, in the second half of 2019 -Neuren...

August 06 2018
Business Wire

American Stock Exchange to Trade Options on Five New Securities

NEW YORK, April 12 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Thursday, April 13, 2006 on the following Nasdaq Stock Market and New York Stock...

April 12 2006
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6854.9637681159413.814.8313.6275987614.33560334DE
42.18517.764227642312.314.8310.960224212.79401615DE
121.53511.853281853312.9517.9410.962600013.52883959DE
26-5.965-29.168704156520.45170.0910.956392614.10738699DE
52-9.025-38.38792003423.51170.0910.951503716.98022632DE
15611.285352.656253.2170.093.0446824313.18713865DE
26011.655411.837455832.83170.090.96535173710.99708223DE

NEU - Frequently Asked Questions (FAQ)

What is the current Neuren Pharmaceuticals share price?
The current share price of Neuren Pharmaceuticals is AUD 14.485
How many Neuren Pharmaceuticals shares are in issue?
Neuren Pharmaceuticals has 127,695,676 shares in issue
What is the market cap of Neuren Pharmaceuticals?
The market capitalisation of Neuren Pharmaceuticals is AUD 1.85B
What is the 1 year trading range for Neuren Pharmaceuticals share price?
Neuren Pharmaceuticals has traded in the range of AUD 10.90 to AUD 170.09 during the past year
What is the PE ratio of Neuren Pharmaceuticals?
The price to earnings ratio of Neuren Pharmaceuticals is 11.77
What is the cash to sales ratio of Neuren Pharmaceuticals?
The cash to sales ratio of Neuren Pharmaceuticals is 7.97
What is the reporting currency for Neuren Pharmaceuticals?
Neuren Pharmaceuticals reports financial results in NZD
What is the latest annual turnover for Neuren Pharmaceuticals?
The latest annual turnover of Neuren Pharmaceuticals is NZD 231.94M
What is the latest annual profit for Neuren Pharmaceuticals?
The latest annual profit of Neuren Pharmaceuticals is NZD 157.08M
What is the registered address of Neuren Pharmaceuticals?
The registered address for Neuren Pharmaceuticals is SUITE 201, 697 BURKE ROAD, CAMBERWELL, VIC 3124, AUCKLAND
What is the Neuren Pharmaceuticals website address?
The website address for Neuren Pharmaceuticals is www.neurenpharma.com
Which industry sector does Neuren Pharmaceuticals operate in?
Neuren Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATHOAlterity Therapeutics Limited
AUD 0.012
(200.00%)
109.48M
ATHAlterity Therapeutics Ltd
AUD 0.018
(125.00%)
445.78M
NRZONeuRizer Ltd
AUD 0.002
(100.00%)
440k
VPRVolt Group Ltd
AUD 0.002
(100.00%)
5.01k
SFGSeafarms Group Limited
AUD 0.002
(100.00%)
132.21k
HYDHydrix Limited
AUD 0.015
(-31.82%)
1.92M
CNJConico Ltd
AUD 0.007
(-30.00%)
4.34M
FG1OFlynn Gold Limited
AUD 0.005
(-28.57%)
325.02k
MIOMacarthur Minerals Ltd
AUD 0.031
(-27.91%)
277.59k
ACWODActinogen Medical Limited
AUD 0.008
(-27.27%)
200k
ATHAlterity Therapeutics Ltd
AUD 0.018
(125.00%)
445.78M
ATHOAlterity Therapeutics Limited
AUD 0.012
(200.00%)
109.48M
ZIPZip Co Limited
AUD 2.44
(-25.15%)
80.5M
VFXVisionflex Group Ltd
AUD 0.0025
(-16.67%)
76.79M
EELENRG Elements Ltd
AUD 0.001
(0.00%)
76.35M

Discussion

View Full Feed
ron_66271 ron_66271 5 minutes ago
CTS are in the Same Camp as Preferred Shares.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 10 minutes ago
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 11 minutes ago
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 13 minutes ago
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 14 minutes ago
Thanks for the input...
ALYI
littlejohn littlejohn 21 minutes ago
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 22 minutes ago
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 24 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 24 minutes ago
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
dinogreeves dinogreeves 28 minutes ago
SMCI after the report it will get to the right valuation with time.
SMCI
dinogreeves dinogreeves 29 minutes ago
DeepSeek is fake.
SMCI
toogoodfella toogoodfella 30 minutes ago
IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
YOULL BECOME VERY FAMOUS

LEHNQ
trader53 trader53 31 minutes ago
DPLS 0.0004 - Point of Maximum Financial Opportunity


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________
DPLS MFI
fuagf fuagf 34 minutes ago
Just hearing of it now on our news. Terrible!!!
Susie924 Susie924 34 minutes ago
There wasn’t much to hear but there was definitely a gasp at one point.
Kool Aid Man Kool Aid Man 35 minutes ago
Shieldcom's only 'contact' is a mail drop at their registered agent's office --Corporation Trust Center in Delaware. 'In 2012, it was the registered agent address of at least 285,000 separate American and foreign businesses who operate or trade in the United States'
https://en.wikipedia.org/
MONI
jjmentat jjmentat 38 minutes ago
Did you try Ebay??????
You know what they say........If you can't get it on Ebay or Walmart.......you're out of luck.......LOL
Fredddddy Fredddddy 38 minutes ago
Yes. I had been waiting on a good spot. Unfortunately came down with stomach bug Tuesday. (Thank you children). So I’m just getting back to level. And I missed it. On side lines waiting for entry.
XMaster2023 XMaster2023 39 minutes ago
Approval Tomorrow? It’s time!
NWBO
blackcat blackcat 39 minutes ago
Thanks- for some reason it won't load. I'll try it on my other laptop later.
"Something went wrong. Try reloading".
Ray_137 Ray_137 43 minutes ago
April fool's day! Like tons of other predictions.
COOP
noradio noradio 49 minutes ago
Why should a US listed company, that's fully reporting and audited and has disclosed all it needs to disclose. Be halted because Canadian regulators need a vote?
TWOH
jeunke22 jeunke22 52 minutes ago
Here is an interesting article on Apple and GAI confirming your opinion. The market for speed bandwidth, low latency and small form factor of optical engines over fiber connections will take another leap forward.
https://www.techradar.com/pro/apple-is-the-biggest-winner-of-deepseeks-new-ai-b
LWLG

Your Recent History

ASX
NEU
Neuren Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads